Search

Your search keyword '"C-100-21 Study Group"' showing total 1 results

Search Constraints

Start Over You searched for: Author "C-100-21 Study Group" Remove constraint Author: "C-100-21 Study Group"
1 results on '"C-100-21 Study Group"'

Search Results

1. Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

Catalog

Books, media, physical & digital resources